Neurological
-
ADHD
ADHD, also more commonly known as Attention-Deficit/Hyperactivity Disorder, is one of the most prevalent neurodevelopmental disorders affecting children in Canada today. It is characterized by a wide variety of behavioural problems, including impulsiveness, inattention, and in some cases, even hyperactivity. It can also occur in conjecture with other health problems such as dyslexia, insomnia, and issues with anger management.
There are three main behavioural changes that parents of young children should watch for. Those are restlessness, distractibility, and as mentioned previously, impulsivity. Children with ADHD are often easily distracted by things they hear, see or think, fidget and cannot sit still for long periods of time, and also tend to make decisions before thinking them through. Secondary symptoms of ADHD include feelings of anxiousness, being disorganized, or procrastination. These symptoms typically more prominent between the ages of 3 and 5, but can also affect older children, too – and while these symptoms are certainly a precursor for ADHD, they can also be signs of other mental health issues.
It is important to address signs of ADHD as early as possible. The longer you wait, the more difficulty your child may have – not only with school, but in their social interactions as well. In order to determine whether or not your child has ADHD, healthcare professionals will take an in-depth look into the child’s medical history – including whether or not there is any family history of ADHD, the child’s development/skills, as well as the presence of any other comorbidities, such as anxiety, which is also common with ADHD. Teachers may also be asked to relay information back to healthcare professionals about how a child behaves in the classroom, as this can be helpful in determining a proper course of treatment for the child.
There is no cure for ADHD. There are, however, many ways in which symptoms of ADHD can be controlled.
Though it can be a difficult decision for parents of children to make, medication has been shown to be beneficial in treating children with ADHD. Central Nervous System stimulants, for example, help to improve the child’s ability to focus, while other non-stimulant medications can help to improve memory and attention. As with most medication, ADHD medications also come with side effects; the most common being having difficulty sleeping, headaches, dry mouth, nausea, irritability, nervousness, and weight loss. Generally, these side effects will go away after a few weeks. There are, however, other, more serious side effects that can also occur as a result of taking such medications, including allergic reactions, high blood pressure, having thoughts of suicide, or hallucinations.
If you notice your child exhibiting any of these symptoms, it is important that you speak with your physician or paediatrician as soon as possible.
-
Meningitis Risks, Signs, and Prevention
Meningitis is a serious and often life-altering infection that has the potential to strike anyone, anywhere, and at any time, regardless of age or location. This illness, which affects the membranes surrounding the brain and spinal cord, can lead to an array of severe symptoms and complications that highlight its devastating nature. Affecting over 2.5 million people worldwide each year, meningitis leaves a powerful impact on individuals and families alike, with fatal outcomes in approximately one out of every ten cases. The impact is especially heartbreaking in children under five, who account for nearly half of all meningitis-related deaths worldwide. Surviving meningitis often comes with its own challenges, as roughly one in five survivors live with long-term disabilities, such as hearing loss, brain damage, epilepsy, and even the need for limb amputation. Given the significant impact and the indiscriminate nature of this infection, understanding the symptoms, risk factors, and treatment options is essential for both awareness and prevention.
The symptoms of meningitis, while often mistaken for other ailments in the early stages, can progress rapidly, especially in individuals over the age of two. Common signs include a sudden high fever and stiffness in the neck, accompanied by a severe headache. Other indications might involve nausea, vomiting, and in some cases, confusion or difficulty concentrating. As the infection progresses, seizures, drowsiness, and heightened sensitivity to light can also arise, while appetite loss and, in certain cases like meningococcal meningitis, a skin rash may occur. Recognizing these symptoms is crucial, as early intervention can significantly improve outcomes, especially for bacterial meningitis, which is notably the most severe form of the illness.
In infants and newborns, meningitis symptoms can present differently, adding an additional layer of complexity for concerned parents and caregivers. High fever, continuous crying, and pronounced irritability are some of the first signs. An infected infant may also become notably sleepy, difficult to wake, or display sluggishness or inactivity. Additional signs may include a reluctance to eat or wake for feeding, poor feeding habits, vomiting, and, in some cases, a visible bulge in the soft spot atop the baby’s head. Newborns may also develop stiffness in their neck and body, and in many cases, attempts to console the child may only lead to more intense crying, particularly when the infant is held. This variation in symptoms across age groups underscores the need for parents and caregivers to be vigilant and to seek prompt medical advice when these symptoms appear.
Meningitis can be caused by several infectious agents, including viruses, bacteria, fungi, and parasites. While viral meningitis is the most common and often resolves with minimal medical intervention, bacterial meningitis presents a much more severe threat. Left untreated, bacterial meningitis can lead to death within a matter of days, and delayed treatment increases the likelihood of lasting brain damage. Unlike viral cases, bacterial meningitis demands immediate antibiotic treatment, making early diagnosis and intervention vital to prevent life-threatening complications. While some forms of meningitis improve with limited treatment, others require urgent medical intervention to prevent a rapid escalation of symptoms and potentially fatal outcomes.
Immediate medical care is imperative if there is any suspicion of meningitis, whether it is a family member, friend, or oneself. Early treatment, particularly for bacterial meningitis, can avert many of the infection’s most serious complications and reduce the chance of long-term effects.
-
Living with MS in Canada
Canada is recognized as having one of the highest rates of multiple sclerosis (MS) globally, with an estimated 90,000 Canadians currently living with this debilitating disease. The gravity of the situation becomes apparent when considering that, on average, 12 Canadians are diagnosed with MS every single day. This chronic illness predominantly affects individuals between the ages of 20 and 49, marking the beginning of a lifelong struggle against its unpredictable and often progressive nature.
Multiple sclerosis is a complex neurological disorder that targets the central nervous system, encompassing the brain, spinal cord, and optic nerves. Classified as an episodic disability, MS is characterized by its varying severity and duration of symptoms and disability, which can range from mild and transient episodes to more severe and permanent impairments. The disease fundamentally attacks myelin, the protective sheath that envelops nerve fibres, leading to inflammation and, in many cases, significant damage to this critical protective layer. Myelin is essential for the efficient transmission of nerve impulses across the nervous system; hence, even minor damage can cause disruptions in these impulses. In cases where the damage is extensive, scar tissue may form in place of myelin, completely disrupting nerve signal transmission and potentially causing irreversible damage to the nerve fibres themselves.
The unpredictability of MS manifests through a wide array of both physical and mental symptoms. Physically, individuals may experience extreme fatigue, lack of coordination, muscle weakness, tingling sensations, and impaired sensory perceptions. Vision problems, bladder issues, and difficulties with mobility are also common. Mentally, MS can lead to cognitive impairments and significant mood changes, severely impacting a person’s quality of life and their ability to perform daily activities. This variability in symptoms and their progression underscores the complexity of managing and living with the disease.
Diagnosing multiple sclerosis is a meticulous process that relies heavily on a thorough medical history and comprehensive neurological examination. While no single test can definitively diagnose MS, several diagnostic tools are instrumental in confirming the presence of the disease. Magnetic Resonance Imaging (MRI) is often used to detect lesions in the central nervous system, indicative of MS-related damage. Additionally, evoked potential tests, which measure the electrical activity in the brain in response to stimuli, and lumbar punctures, which analyze cerebrospinal fluid, can provide further evidence to support a diagnosis. Critical to the diagnosis of MS is the requirement for evidence of disease activity separated by time (lesions that have formed at different points in time) and space (lesions in at least two distinct areas of the central nervous system). This criterion ensures that the diagnosis reflects the episodic nature of the disease, rather than a singular, isolated incident.
It is crucial to understand that diagnosing MS is a process of exclusion. Physicians must rule out other potential causes for the symptoms before confirming a diagnosis of MS. This comprehensive approach helps ensure that individuals receive an accurate diagnosis, allowing for more effective management and treatment of the disease. The journey to diagnosis can be long and fraught with uncertainty, but it is a vital step towards understanding and managing this complex neurological condition.
In conclusion, the high prevalence of multiple sclerosis in Canada highlights the need for continued research, awareness, and support for those affected by the disease. Understanding the intricacies of MS, from its impact on the nervous system to the diagnostic challenges it presents, is essential for healthcare providers, patients, and their families. As the medical community continues to advance in its knowledge and treatment of MS, there remains a hopeful prospect for better management strategies and, ultimately, a cure for this life-altering disease.
-
Concussion Awareness
Concussions are a type of traumatic brain injury that result from a blow to the head or a sudden, violent motion that causes the brain to move within the skull. This movement can lead to temporary loss of normal brain function, affecting cognitive processes, physical abilities, and emotional well-being. Recognizing the signs of a concussion, knowing how to proceed with diagnosis and treatment, and understanding preventive measures are essential for managing this condition effectively.
What Part of the Body Concussions Affect
Concussions primarily affect the brain, the control center for all bodily functions. The brain is cushioned by cerebrospinal fluid within the skull, but a sudden impact or abrupt movement can cause it to collide against the skull’s inner walls. This impact can damage brain cells and create chemical changes in the brain, leading to a temporary disruption in its normal functioning.
Symptoms of Concussions
The symptoms of a concussion can vary widely depending on the individual and the severity of the injury. They may appear immediately after the incident or may be delayed for hours or days. Common symptoms include headache, confusion, dizziness, ringing in the ears, nausea or vomiting, slurred speech, and fatigue. Some individuals may experience sensitivity to light and noise, sleep disturbances, memory or concentration problems, and mood changes. It’s crucial to monitor anyone who has suffered a potential concussion closely, as symptoms can evolve over time.
Diagnosing Concussions
The diagnosis of a concussion involves a thorough evaluation by a healthcare professional. This evaluation may include a detailed history of the incident, a physical examination, and cognitive tests to assess memory, concentration, and other aspects of brain function. In some cases, imaging tests such as a CT scan or MRI may be recommended to rule out more severe injuries like brain bleeding or swelling. However, it’s important to note that concussions often cannot be seen on these imaging tests, as they assess the structure of the brain and not its functionality.
Treatment and Recovery
The cornerstone of concussion treatment is rest and gradually returning to normal activities under the guidance of a healthcare professional. Physical and cognitive rest is crucial in the early stages to allow the brain to heal. This means avoiding activities that require concentration and physical exertion, including screen time, reading, and sports. As symptoms improve, individuals can slowly start to reintegrate into their daily routines, but this process should be tailored to each person’s recovery pace. In some cases, rehabilitation therapies, such as physical therapy, occupational therapy, or speech therapy, may be necessary to address specific symptoms or complications.
Prevention of Concussions
Preventing concussions involves taking precautions during activities that pose a risk of head injury. Wearing appropriate protective gear, such as helmets, during sports or recreational activities is essential. Adhering to safety rules and regulations, ensuring safe playing environments, and teaching proper techniques can also significantly reduce the risk of concussions. Educating individuals about the dangers of head injuries and the importance of reporting and seeking treatment for any head trauma can foster a safer environment for everyone.
-
Breakthrough Blood Test for Alzheimer’s
In the continuously evolving and ever-expansive landscape of medical diagnostics, particularly in the domain of neurodegenerative diseases, a recent groundbreaking study has emerged, offering a beacon of hope for the early detection and, consequently, more effective management of Alzheimer’s disease. Central to this pivotal research is the innovative utilization of a blood test, specifically designed to detect the presence of a specific protein, known in the medical community as phosphorylated tau or p-tau. This development is not merely an incremental advancement; it represents a potential paradigm shift in our approach to diagnosing Alzheimer’s, promising not just early detection but also heralding a more accessible, cost-effective alternative to the traditional, more invasive methods currently in use.
Elucidated in a recent publication within the esteemed and widely respected journal, JAMA Neurology, this study delves deeply into the intricate and nuanced efficacy of this novel blood test, targeting a key biomarker of Alzheimer’s disease, namely p-tau217. This biomarker, p-tau217, has attracted considerable attention within the scientific and medical communities, primarily due to its established correlation with the accumulation of other pathognomonic proteins – notably, beta-amyloid and tau – within the cerebral architecture of individuals diagnosed with Alzheimer’s disease. Traditionally, the identification and quantification of these proteins have necessitated the utilization of either cerebral imaging modalities or cerebrospinal fluid analysis through lumbar puncture, methodologies that are often fraught with challenges, including but not limited to limited accessibility, significant financial implications, and a certain degree of invasiveness. In stark and welcome contrast, the simplicity, non-invasiveness, and relative ease of administration of a blood test present a radical shift, potentially redefining the clinical approach to Alzheimer’s diagnostics in the years to come.
The study’s findings are, in no uncertain terms, groundbreaking. The blood test demonstrated a staggering 96% accuracy rate in detecting elevated levels of beta-amyloid and an even more impressive 97% accuracy in identifying tau accumulations. These percentages are not mere statistical notations; they are indicative of the test’s extraordinary reliability and underscore its potential role as a transformational tool in the early detection of Alzheimer’s disease. The far-reaching implications of such early detection are immense, proffering a critical window for therapeutic intervention well before the clinical manifestation of symptoms. This, in turn, could potentially alter the trajectory of the disease and significantly enhance patient outcomes.
The significance and transformative potential of these findings have resonated deeply within the global scientific community. Renowned experts in the field, like Dr. Ashton, have echoed a sentiment long held by many researchers and clinicians alike: the utilization of blood tests to measure tau or other biomarkers is on the brink of revolutionizing our understanding and management of Alzheimer’s disease. Dr. Ashton’s assertion that “we are close to these tests being prime-time” encapsulates not just the excitement but also the profound optimism that is currently permeating the research community about this development.
Alzheimer’s disease, a neurodegenerative disorder that progressively impairs memory and cognitive functions, remains the most common form of dementia, representing a significant public health challenge. According to the National Institutes of Health, Alzheimer’s has long been a source of grave concern, not only due to its insidious nature but also because of the profound impact it has on patients, families, and healthcare systems globally. The advent of a reliable, non-invasive, and relatively straightforward blood test for its early detection marks an epochal advancement in the realm of Alzheimer’s care. It represents not just a step forward in clinical practice but a monumental leap towards changing the very landscape of Alzheimer’s diagnosis and management, lighting a path towards earlier, more effective intervention strategies.
-
Managing Stress-Related Headaches
In the fast-paced rhythm of modern life, stress has become an inescapable companion for many, often manifesting itself through physical symptoms. One such common physical manifestation is stress-related headaches, a discomfort that a significant portion of the population experiences. Understanding the intricate link between stress and headaches, and learning how to manage these headaches, is essential for both physical and mental well-being.
The Connection Between Stress and Headaches
Headaches, in their various forms, are among the most prevalent health complaints. When we consider stress-related headaches, we primarily refer to tension-type headaches and migraines, both of which are significantly influenced by stress. Tension-type headaches, characterized by a dull, aching sensation and a feeling of tightness or pressure across the forehead or on the sides and back of the head, are commonly linked to stress. Stress triggers muscle tension and contraction, leading to this type of headache. On the other hand, migraines, which present as a throbbing pain often accompanied by nausea, vomiting, and sensitivity to light and sound, can be exacerbated by stress as well. Physiologically, stress leads to the activation of the body’s “fight or flight” response, resulting in the release of chemicals like adrenaline and cortisol. These chemical changes can influence the blood vessels and nerves in the brain, leading to headaches.
Psychological Factors and Stress-Related Headaches
The psychological aspect of stress-related headaches is as significant as the physiological one. Stress can stem from various sources: work pressure, personal relationships, financial worries, or chronic health issues. The body’s reaction to these stressors, both psychologically and physically, often culminates in a headache. Additionally, the fear of headache recurrence can create a cycle of anxiety and stress, further perpetuating the problem.
Managing Stress-Related Headaches
Addressing stress-related headaches involves a dual approach: managing the headaches themselves and tackling the underlying stress.
Medical Treatment
Over-the-counter pain relievers like acetaminophen, ibuprofen, or aspirin can be effective for occasional stress-related headaches. However, their overuse can lead to medication-overuse headaches, a condition where the frequent use of headache medications paradoxically leads to more headaches. For chronic or severe cases, a healthcare provider may prescribe other medications, such as tricyclic antidepressants, which can prevent headaches by affecting the levels of serotonin and other chemicals in the brain.
Stress Management Techniques
Incorporating stress management techniques into daily life is crucial. Techniques such as deep breathing exercises, progressive muscle relaxation, and mindfulness meditation have proven effective in reducing stress levels. Regular physical activity, adequate sleep, and a balanced diet also play a vital role in stress management.
Cognitive-Behavioral Therapy (CBT)
CBT, a type of psychotherapy, is highly effective in managing stress and anxiety. It involves identifying and challenging negative thought patterns and behaviors and replacing them with healthier ones. CBT can help individuals develop coping strategies to handle stress better, potentially reducing the frequency and severity of stress-related headaches.
Lifestyle Modifications
Making lifestyle changes can have a profound impact on managing stress-related headaches. This includes establishing a regular sleep pattern, engaging in regular physical activity, maintaining a healthy diet, and avoiding known headache triggers like certain foods, dehydration, or lack of sleep.
Stress-related headaches are a tangible manifestation of the psychological and physical strain that stress places on the body. While medications can provide relief, a comprehensive approach that includes stress management techniques, lifestyle modifications, and professional support is crucial for long-term management. Understanding the link between stress and headaches and adopting proactive measures can significantly improve quality of life, turning a pain in the head into a problem that can be effectively managed and controlled.
-
Understanding Alzheimer’s: A Guide for Canadians
January marks a significant month in Canada – Alzheimer’s Awareness Month. Spearheaded by the Alzheimer Society, this initiative sheds light on Alzheimer’s disease, a condition that touches the lives of many Canadians. Here, we delve into the intricacies of Alzheimer’s, exploring its nature, who it affects, and the impact it has on individuals, families, and society.
What is Alzheimer’s Disease?
Alzheimer’s disease is a progressive neurodegenerative disorder that impairs memory and cognitive functions. It’s the most common form of dementia, accounting for 60-70% of cases. The disease is characterized by the accumulation of amyloid plaques and tau tangles in the brain, leading to neuronal damage and brain atrophy.
The Canadian Context
In Canada, Alzheimer’s disease is not just a medical concern but a growing public health issue. As of April 2023, over half a million Canadians live with dementia, with Alzheimer’s constituting a significant proportion. The aging population in Canada means these numbers are expected to rise, increasing the burden on healthcare systems and caregivers.
Who Gets Alzheimer’s?
Alzheimer’s primarily affects older adults. The risk increases with age, particularly after 65 years. However, early-onset Alzheimer’s can occur in individuals in their 40s or 50s, though it’s less common.
Several factors influence the risk of developing Alzheimer’s:
- Genetic Factors: Certain genes increase the risk. The most well-known is the APOE-e4 allele, though it’s not a definitive predictor.
- Family History: Having a first-degree relative with Alzheimer’s increases one’s risk.
- Lifestyle and Heart Health: Factors like smoking, obesity, diabetes, hypertension, and high cholesterol might increase risk.
- Head Injuries: Significant head trauma has been linked to a higher risk of Alzheimer’s.
- Social and Cognitive Engagement: Lower levels of social interaction and mental stimulation may be risk factors.
Symptoms and Progression
Alzheimer’s disease manifests gradually, starting with mild memory loss and escalating to severe cognitive and functional impairments. Key symptoms include:
- Memory loss affecting daily activities
- Difficulty performing familiar tasks
- Problems with language and communication
- Disorientation to time and place
- Poor or decreased judgment
- Misplacing things
- Changes in mood, behavior, and personality
- Withdrawal from social activities
As the disease progresses, individuals may require comprehensive care and assistance with daily living.
Diagnosis and Treatment
Diagnosing Alzheimer’s involves a comprehensive assessment, including medical history, physical examination, neurological tests, and brain imaging. While there’s no cure yet, treatments focus on managing symptoms and enhancing quality of life. Medications like cholinesterase inhibitors and memantine can help with cognitive symptoms. Supportive therapies, lifestyle changes, and caregiving strategies are crucial in managing the disease.
The Role of Alzheimer’s Awareness Month in Canada
Alzheimer’s Awareness Month plays a vital role in:
- Educating the Public: Increasing awareness about Alzheimer’s, its symptoms, and impact.
- Supporting Research: Highlighting the need for research to find a cure and improve treatments.
- Advocating for Patients and Families: Providing resources and support for those affected.
- Policy and Healthcare Planning: Influencing policies to better address the needs of individuals with Alzheimer’s.
Alzheimer’s disease remains a significant challenge in Canada, affecting individuals, families, and communities. Through initiatives like Alzheimer’s Awareness Month, we can hope to foster a greater understanding, improve care, and ultimately find a cure. As a family physician, I urge Canadians to engage with these initiatives, support research, and advocate for those living with this debilitating condition. Remember, awareness is the first step towards change.
-
PVNH Disorder
Periventricular Nodular Heterotopia (PVNH) is a rare neurological disorder that is characterized by the malpositioning of neurons in the brain. “Periventricular” refers to the region around the brain ventricles, and “nodular heterotopia” describes the presence of nodules, or small aggregations of nerve cells, that are out of place. During normal brain development, neurons migrate from their place of origin to their final destination. In PVNH, this migration is disrupted, and neurons form nodules in inappropriate areas, particularly near the ventricles.In most cases, PVNH is due to mutations in the FLNA gene, which encodes a protein crucial for cell movement and structure. This disorder follows an X-linked dominant inheritance pattern. Given the nature of the genetic transmission, females who have a single mutated X chromosome can exhibit the disorder, while males with the mutation are usually not viable and often die in utero or shortly after birth.
PVNH affects approximately 1 in 10,000 individuals worldwide, according to current estimates. However, the exact prevalence may be higher as milder cases can go undiagnosed or misdiagnosed. The disorder is present from birth and affects both sexes, but symptoms typically manifest more frequently and severely in females. This is likely due to the pattern of X-inactivation, a natural process that occurs in females to compensate for having two X chromosomes.
Symptoms of PVNH vary greatly among affected individuals, ranging from asymptomatic to severe. Common signs include recurrent seizures (epilepsy), which usually begin in adolescence or early adulthood; learning disabilities or mild intellectual disability; and, in some cases, coordination or balance problems. Less common manifestations may include cardiovascular defects, bowel or bladder issues, and, in some cases, distinctive facial features.
Diagnosis of PVNH typically involves a combination of clinical evaluation, detailed patient history, and imaging techniques such as magnetic resonance imaging (MRI). The MRI can detect the characteristic nodules that form along the ventricles, thus confirming the diagnosis. Genetic testing is also available and can identify mutations in the FLNA gene.
There is currently no cure for PVNH. Instead, treatment involves managing the symptoms and supporting the patient’s quality of life. For individuals with seizures, antiepileptic drugs (AEDs) are often prescribed. Speech therapy, occupational therapy, and special education services may benefit those with learning or intellectual disabilities. Physical therapy can assist those with motor difficulties. Regular cardiology check-ups may be recommended if cardiovascular defects are present.
Research into targeted therapies for PVNH is ongoing. Emerging evidence suggests potential benefits of mammalian target of rapamycin (mTOR) inhibitors, as they might influence the underlying abnormal cell migration in PVNH. However, further clinical trials are needed to confirm these findings.
In conclusion, PVNH is a complex neurological disorder with significant variability in its presentation. Its diagnosis and management require a multidisciplinary approach involving neurologists, geneticists, therapists, and other healthcare professionals. While there is currently no cure, the ultimate goal is to improve the quality of life for those living with PVNH, fostering their capacity for learning, growth, and overall wellbeing. As our understanding of the disorder grows, there is hope for more effective treatments and interventions in the future.
-
Understanding the Types of Migraines
Migraines are far from a homogeneous affliction. The term “migraine” actually encompasses several different conditions, each with its own unique set of characteristics and symptomatology. The three primary types are migraine without aura, migraine with aura, and chronic migraine. Let’s delve into the intricacies of each.
Migraine Without Aura
Also known as a “common migraine,” migraine without aura is the most prevalent type of migraine. Despite its name, there’s nothing “common” about the intense pain and accompanying symptoms people experience. The pain is typically localized to one side of the head and can range from moderate to severe in intensity. It is often described as a throbbing or pulsating sensation.
Symptoms associated with migraine without aura include sensitivity to light (photophobia), sound (phonophobia), and occasionally smells. Nausea and vomiting are also frequent accompaniments, and the headache is often worsened by physical activity.
Interestingly, some people might experience premonitory symptoms in the hours or days leading up to the headache. These can include mood changes, food cravings, neck stiffness, increased yawning, and fluid retention.
Migraine With Aura
The “classic migraine,” or migraine with aura, is differentiated from its more common counterpart by the presence of an “aura” that precedes the headache. Approximately one in four migraine sufferers experience this type.
Aura symptoms generally develop over a period of several minutes and last less than an hour. They can include a range of neurological disturbances such as visual phenomena (flashing lights, zig-zag lines, blind spots), sensory changes (pins and needles, numbness), and speech or language difficulties. In rare cases, people may experience motor weakness or problems with movement.
The headache phase that follows the aura is much like that of a migraine without aura, including symptoms such as photophobia, phonophobia, and possible nausea or vomiting.
Chronic Migraine
Chronic migraine is a debilitating condition defined by the frequency of the attacks. To be diagnosed with chronic migraine, a person must have a headache on 15 or more days per month for at least three months, and the headache must have migraine features on at least eight days per month.
In addition to the typical migraine symptoms, chronic migraine sufferers might also experience symptoms similar to those of tension-type headaches, such as a pressing or tightening sensation, often on both sides of the head.
Chronic migraines significantly impact a person’s quality of life. People living with this condition may also experience anxiety and depression more frequently than the general population.
In conclusion, while migraines as a whole are characterised by debilitating headache, the different types exhibit unique characteristics. Understanding these types is not only crucial for accurate diagnosis and effective treatment, but also for improving the quality of life of those living with this pervasive condition.
-
June is Migraine Awareness Month
June is Migraine Awareness Month, a critical period of focus on a medical condition that impacts an enormous number of individuals and households. This is especially true in Canada, where migraines are a prevalent issue. According to recent studies, migraines affect 25% of Canadian households. While this number may seem high, the reality of migraines is even more daunting. Within this 25%, between 1% and 2% of these individuals suffer from chronic migraines, a condition that involves having a headache for 15 or more days per month for at least three months. Chronic migraine is a severe neurological disorder that can disrupt lives, strain relationships, and affect a person’s ability to participate in daily activities.
One of the significant challenges in diagnosing and understanding migraines is that they do not show up on standard medical imaging tests, such as CT scans and MRIs. This can lead to frustration and fear for those experiencing the intense, often debilitating pain associated with migraines. The lack of visible evidence may also contribute to misconceptions and misunderstandings about the condition’s severity. The diagnosis of migraines relies primarily on symptoms and the patient’s history. People with migraines often experience severe, throbbing pain, usually on one side of the head. This pain can last anywhere from hours to days and can be so severe that it interferes with daily activities. Associated symptoms can include nausea, vomiting, and extreme sensitivity to light and sound.Migraines are triggered by a range of factors, with the most common triggers being stress, hormonal changes, certain foods and drinks, sensory stimuli like bright lights or strong smells, changes in sleep patterns, and physical exertion. Each person’s trigger may vary, and part of managing migraines is learning what these triggers are and how to avoid them.
When it comes to treatment, migraines require a multifaceted approach. Medications are commonly used, both to prevent migraines from starting and to relieve symptoms once they’ve begun. These may include over-the-counter pain relievers, triptans designed specifically for migraines, and preventive medications for those with frequent or severe migraines. Non-pharmacological strategies also play a vital role in managing migraines. These include lifestyle changes, such as regular sleep and meal schedules, stress management techniques, avoidance of identified triggers, and regular physical activity. In some cases, cognitive-behavioral therapy can help patients cope with the impact of chronic migraines.
Migraine Awareness Month provides an important opportunity for us all to better understand the complexity of migraines and their impact on Canadians. Let’s use this time to raise awareness, share experiences, and work towards better treatments and support for those living with migraines. To learn more about migraines and the Move for Migraine campaign, visit migrainecanada.org. The website provides valuable resources, current research findings, and support for those struggling with migraines, as well as for their families and healthcare providers.
